CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
chlorthalidone +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000513
NCT00000513Phase 3Completed

Trial of Antihypertensive Intervention Management

National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Nov 26, 2013

In Brief

A Phase 3 clinical trial evaluating diet, reducing, diet, sodium-restricted, and 2 other interventions for Cardiovascular Diseases and 3 related conditions. Completed.

Detailed Summary

The objective of the Trial of Antihypertensive Intervention Management (TAIM) was to determine the efficacy of dietary management and/or drug therapy, namely thiazide-like diuretics or a beta-blocker, in the control of mild hypertension. Additionally, the Continuation of the Trial of Antihypertensive Intervention Management (COTAIM) tested the effects of long-term weight reduction, and sodium/potassium changes added to weight reduction, as well as the original drug treatment, on the failure rate of blood pressure control.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
19841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 28, 1999
Enrollment StartApr 1, 1984
Study CompletionNov 1, 1994
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

diet, reducingbehavioral

diet, sodium-restrictedbehavioral

chlorthalidonedrug

atenololdrug